Comparative Effectiveness of Entecavir and Lamivudine on Survival of Patients with Chronic Hepatitis B Virus Infection

被引：0
|
作者：
Lim, Young-Suk [1 ]
Heo, Nae-Yun [2 ]
Han, Seungbong [3 ]
An, Jihyun [1 ]
Kim, Gi Ae [1 ]
Suh, Dong Jin [1 ]
机构：
[1] Univ Ulsan, Dept Gastroenterol, Asan Med Ctr, Coll Med, Seoul, South Korea
[2] Inje Univ, Coll Med, Dept Internal Med, Haeundae Paik Hosp, Pusan, South Korea
[3] Univ Ulsan, Coll Med, Dept Clin Epidemiol & Biostat, Asan Med Ctr, Seoul, South Korea
来源：
HEPATOLOGY | 2013年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
32
引用
收藏
页码：223A / 223A
页数：1
相关论文
共 50 条
  • [1] Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection
    Lai, CL
    Rosmawati, M
    Lao, J
    Van Vlierberghe, H
    Anderson, FH
    Thomas, N
    Dehertogh, D
    GASTROENTEROLOGY, 2002, 123 (06) : 1831 - 1838
  • [2] ENTECAVIR RESISTANCE IN ENTECAVIR NAIVE LAMIVUDINE TREATED CHRONIC HEPATITIS B PATIENTS
    Sayan, Murat
    Hulagu, Sadettin
    Akhan, Sila Cetin
    Senturk, Omer
    Meric, Meliha
    Cekmen, Mustafa
    MIKROBIYOLOJI BULTENI, 2009, 43 (03): : 425 - 432
  • [3] CLINICAL EFFECTIVENESS AND COST UTILITY OF ENTECAVIR VERSUS LAMIVUDINE AND ADEFOVIR IN CHRONIC HEPATITIS B VIRUS (HBV) PATIENTS IN MEXICO
    Rely, K.
    Juarez-Garcia, A.
    Salinas Escudero, G.
    Martinez-Rivera, G.
    Alexandre, P. K.
    Donato, B. M.
    VALUE IN HEALTH, 2011, 14 (03) : A120 - A120
  • [4] Entecavir (Baraclude) in patients with chronic hepatitis B virus (HPV) infection
    Sacchi, Viola
    FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2008, 9 (03) : 157 - 161
  • [5] EFFICACY OF ADEFOVIR plus ENTECAVIR COMBINATION THERAPY IN PATIENTS WITH ADEFOVIR OR LAMIVUDINE RESISTANT CHRONIC HEPATITIS B VIRUS INFECTION
    Cho, Yuri
    Kim, Yoon Jun
    Lee, Dong Hyeon
    Lee, Jeong-Hoon
    Cho, Eun Ju
    Jang, Eun Sun
    Kwak, Min-Sun
    Yu, Su Jong
    Yoon, Jung-Hwan
    Lee, Hyo-Suk
    HEPATOLOGY, 2011, 54 : 1062A - 1062A
  • [6] Entecavir for the treatment of chronic hepatitis B virus infection
    Matthews, SJ
    CLINICAL THERAPEUTICS, 2006, 28 (02) : 184 - 203
  • [7] Lamivudine plus adefovir or entecavir for patients with chronic hepatitis B resistant to lamivudine and adefovir
    Heo, Nae-Yun
    Lim, Young-Suk
    Lee, Han Chu
    Chung, Young-Hwa
    Lee, Yung Sang
    Suh, Dong Jin
    JOURNAL OF HEPATOLOGY, 2010, 53 (03) : 449 - 454
  • [8] Evaluation of the cost-effectiveness of entecavir versus lamivudine in hepatitis BeAg-positive chronic hepatitis B patients
    Yuan, Yong
    Iloeje, Uchenna H.
    Hay, Joel
    Saab, Sammy
    JOURNAL OF MANAGED CARE PHARMACY, 2008, 14 (01): : 21 - 33
  • [9] Histological superiority of entecavir to continued lamivudine for the treatment of lamivudine-refractory chronic hepatitis B infection
    Liaw, YF
    Tsai, N
    Hadziyannis, S
    Sette, H
    Goodman, Z
    Cross, A
    Chen, L
    DeHertogh, D
    Hindes, R
    ANTIVIRAL THERAPY, 2004, 9 (06) : H22 - H22
  • [10] Lamivudine treatment in maternally transmitted chronic hepatitis B virus infection patients
    Ni, YH
    Huang, FC
    Wu, TC
    Kong, MS
    Jeng, YM
    Chen, PJ
    Tsuei, DJ
    Chen, HL
    Hsu, HY
    Chang, MH
    PEDIATRICS INTERNATIONAL, 2005, 47 (04) : 372 - 377
12345